Today: 13 November 2025
Subscribe
Browse Category

NYSE:OSCR News 3 October 2025 - 10 November 2025

Oscar Health (OSCR) launches 2026 South Florida plans, adds ‘HelloMeno’; stock in focus — Nov. 10, 2025

Oscar Health (OSCR) launches 2026 South Florida plans, adds ‘HelloMeno’; stock in focus — Nov. 10, 2025

Oscar Health, Inc. (NYSE: OSCR) announced new individual-market plans for South Florida ahead of the 2026 Open Enrollment window and spotlighted HelloMeno, a menopause-focused offering it and partner Elektra Health describe as the first plan of its kind in the individual market. The rollout lands as Washington headlines around ACA premium tax credits pressure managed-care shares broadly; investors are watching OSCR’s intraday action closely. Business Wire+2PR Newswire+2 Key takeaways What Oscar announced today Oscar said it will offer new, affordable individual‑market plans across South Florida for plan year 2026, with options available in Miami‑Dade, Broward, Palm Beach, Martin, and St.
10 November 2025
 ·  ·  ·  ·  · 
Oscar Health (OSCR) Q3 2025: ~$3.0B Revenue, EPS Beats, 2025 Guidance Reaffirmed; Balance Sheet Simplified via Note Exchange — Nov. 6, 2025

Oscar Health (OSCR) Q3 2025: ~$3.0B Revenue, EPS Beats, 2025 Guidance Reaffirmed; Balance Sheet Simplified via Note Exchange — Nov. 6, 2025

What happened in Q3 Oscar Health reported third‑quarter revenue of $2,985,984,000 (in thousands), up from $2,423,482,000 a year ago—about 23% YoY growth, driven largely by higher membership. The medical loss ratio (MLR) increased to 88.5% (from 84.6%), which the company tied to a $130M net risk‑adjustment transfer accrual reflecting higher average market morbidity; this was partly offset by $84M of favorable prior‑period development and $22M favorable intra‑year development. The SG&A expense ratio improved to 17.5% (from 19.0%), reflecting cost discipline and fixed‑cost leverage. Business Wire On the bottom line, Oscar posted a net loss of $137.5M (–$0.53/share) versus a $54.6M
6 November 2025
 ·  ·  ·  ·  · 
Oscar Health Stock Skyrockets on AI-Fuelled Growth Plans – Analysts Warn of ACA Risks

Oscar Health Stock Skyrockets on AI-Fuelled Growth Plans – Analysts Warn of ACA Risks

Key Facts: – Oscar Health (NYSE: OSCR) shares have surged in early October 2025, recently trading around $21–22 (up ~40% YTD) ts2.tech marketbeat.com. The stock hit about $21.50 on Oct 3 (+11% on the day) and was trading near $21.76 on Oct 14 (+6.7%) ts2.tech marketbeat.com. – Oscar announced a $410 million convertible debt offering in September 2025 to fund AI-driven technology and growth initiatives ts2.tech. Proceeds will back “strategic initiatives focused on AI” and expansion of member services businesswire.com ts2.tech. – The company also forged a major partnership with Midwestern grocer Hy‑Vee: launching “Hy‑Vee Health with Oscar”, an employer
17 October 2025
 ·  ·  ·  ·  · 
Oscar Health (OSCR) Stock Surges on Expansion Plans – What Analysts Are Saying

Oscar Health (OSCR) Stock Skyrockets on ACA Hopes and Tech-Driven Growth – Can the Insurtech Finally Turn a Profit?

Financial Performance & Q2 2025 Results Oscar Health’s Q2 2025 results showed rapidly growing revenue but steep losses. Revenue was $2.86 billion, up ~29% from $2.22 billion a year earlier beckerspayer.com. This growth stemmed largely from higher membership – Oscar served over 2.0 million members by mid-2025 (28% growth YoY) beckerspayer.com. However, costs ballooned: Oscar’s medical loss ratio (MLR) jumped to 91.1% in Q2 2025 (vs. 79.0% in Q2 2024) beckerspayer.com. The company attributed this to an increase in average member morbidity and higher-than-expected risk in the ACA population. The operating result was a $230 million loss (vs. $67.8M operating income in Q2 2024),
6 October 2025
 ·  ·  ·  ·  · 
Oscar Health (OSCR) Stock Surges on Expansion Plans – What Analysts Are Saying

Oscar Health (OSCR) Stock Skyrockets – Major News & Analyst Insights (Oct 2025)

Key Facts: Oscar Health’s stock recently jumped to roughly $21.5 on Oct 3, 2025 (up ≈11% that day) indmoney.com. Over the past week, the stock is up about 8% marketscreener.com. In Q2 2025, Oscar reported $2.9 billion revenue (+28–30% YoY) but a $228 million net loss ($0.89/share) due to a high medical loss ratio tradingview.com. Management has reaffirmed full-year 2025 guidance (revenues ~$11.2–11.3 B, operating income $225–275 M) at the Wells Fargo conference ainvest.com ainvest.com, and in July raised its revenue outlook to ~$12.0–12.2 B (but warned medical costs would be higher, with MLR ~86–87%) investing.com. Analysts are broadly bearish: MarketBeat shows a consensus “Strong
3 October 2025
 ·  ·  ·  ·  · 
Go toTop